Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
The second episode of our ‘Enabling Successful Sites’ series features a discussion between Karen McIntyre (Vice President, Global Site Alliances), Xoli Belgrave (Sr. Director, Head of Clinical Trial Diversity and Inclusion), Jamie Langley (Executive Director, Parexel Academy) and Dr. Lovie Negrin, CEO and Founder of Randomize now on how we can empower and leverage sites with the tools and training they need to more successfully recruit diverse patient populations for their studies. They talk about the impact of not including diverse patient populations in studies is discussed, the need for sponsors and CROs to share their diversity, equity, and inclusion strategies with investigator sites, and soft skills site staff need to have for necessary conversations.
Episode 1: Site feasibility and study start-up challenges
Episode 3: Taking the complexity out of oncology clinical trials
Episode 4: Partnering with sites to improve patient recruitment and retention
Episode 5: Strategies for improving communication between sites, sponsors and CROs
Related Insights
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Blog
Operational strategies for faster, more efficient pivotal NSCLC trials
Sep 17, 2025
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Article
Making rare disease drug development personal
Jan 8, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Podcast
Enabling Successful Sites: Episode 5, Part One: Strategies for improving communication between sites, sponsors and CROs
Feb 24, 2025
Webinar
Navigating the complexities of AML drug development
Oct 30, 2024
Blog
SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change
Aug 24, 2022
Related Insights
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Blog
Operational strategies for faster, more efficient pivotal NSCLC trials
Sep 17, 2025
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Article
Making rare disease drug development personal
Jan 8, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Podcast
Enabling Successful Sites: Episode 5, Part One: Strategies for improving communication between sites, sponsors and CROs
Feb 24, 2025
Webinar
Navigating the complexities of AML drug development
Oct 30, 2024
Blog
SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change
Aug 24, 2022